MYC rearrangements have been found in 0-15% of unselected PCM but in 45% of advanced tumors, particularly in those with extramedullary involvement, and in 65% of PCM cell lines, suggesting that MYC structural alterations are associated with progression of the tumors [71, 96, 97]. This evidence concerns the gene MYC and paracoccidioidomycosis.